Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Chemotherapy of head and neck cancer enhanced by gene therapy

Aug. 9, 2000

Tamoxifen plus cisplatin improves survival in melanoma patients

Aug. 9, 2000

HumaRAD pilot clinical results reported for head and neck cancer

Aug. 9, 2000

DNA topoisomerase II inhibitors under study at Lafon

Aug. 8, 2000

New serine protease inhibitors useful for treating cancer

Aug. 8, 2000

PR-000350 shows promise in improving efficacy of radiation therapy

Aug. 8, 2000

Cell Pathways completes phase Ib trial of CP-461

Aug. 7, 2000

Pfizer discontinues phase III trials of prinomastat in advanced cancers

Aug. 7, 2000

Cyclin-dependent kinase inhibitors under study at Roche

Aug. 4, 2000

Foscan PDT shows promise as treatment for head and neck cancer

Aug. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....